 | • レポートコード：QYR2104Z5210 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、性索性腺間質腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、手術、その他）、用途別市場規模（病院、診療所、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・性索性腺間質腫瘍治療の市場動向 ・企業の競争状況、市場シェア ・性索性腺間質腫瘍治療の種類別市場規模（化学療法、放射線療法、手術、その他） ・性索性腺間質腫瘍治療の用途別市場規模（病院、診療所、がん研究センター、その他） ・性索性腺間質腫瘍治療の北米市場規模2016-2027（アメリカ、カナダ） ・性索性腺間質腫瘍治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・性索性腺間質腫瘍治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・性索性腺間質腫瘍治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・性索性腺間質腫瘍治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Danaher、Roche、BD、Boston Scientific、Johnson & Johnson、Bio-Rad、Merck Millipore、Agilent Technologies、Thermo Fisher Scientific、Qiagen、PerkinElmer、CooperSurgical） ・結論 |
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes.
Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market
The global Sex Cord Gonadal Stromal Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sex Cord Gonadal Stromal Tumor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sex Cord Gonadal Stromal Tumor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sex Cord Gonadal Stromal Tumor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sex Cord Gonadal Stromal Tumor Treatment market.
Global Sex Cord Gonadal Stromal Tumor Treatment Scope and Market Size
Sex Cord Gonadal Stromal Tumor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sex Cord Gonadal Stromal Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiotherapy
Surgery
Others
Segment by Application
Hospitals
Clinics
Cancer Research Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Danaher
Roche
BD
Boston Scientific
Johnson & Johnson
Bio-Rad
Merck Millipore
Agilent Technologies
BD
Boston Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Surgery
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Perspective (2016-2027)
2.2 Sex Cord Gonadal Stromal Tumor Treatment Growth Trends by Regions
2.2.1 Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sex Cord Gonadal Stromal Tumor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Sex Cord Gonadal Stromal Tumor Treatment Industry Dynamic
2.3.1 Sex Cord Gonadal Stromal Tumor Treatment Market Trends
2.3.2 Sex Cord Gonadal Stromal Tumor Treatment Market Drivers
2.3.3 Sex Cord Gonadal Stromal Tumor Treatment Market Challenges
2.3.4 Sex Cord Gonadal Stromal Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Revenue
3.1.1 Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Revenue (2016-2021)
3.1.2 Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Treatment Revenue
3.4 Global Sex Cord Gonadal Stromal Tumor Treatment Market Concentration Ratio
3.4.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sex Cord Gonadal Stromal Tumor Treatment Revenue in 2020
3.5 Sex Cord Gonadal Stromal Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Sex Cord Gonadal Stromal Tumor Treatment Product Solution and Service
3.7 Date of Enter into Sex Cord Gonadal Stromal Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sex Cord Gonadal Stromal Tumor Treatment Breakdown Data by Type
4.1 Global Sex Cord Gonadal Stromal Tumor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Type (2022-2027)
5 Sex Cord Gonadal Stromal Tumor Treatment Breakdown Data by Application
5.1 Global Sex Cord Gonadal Stromal Tumor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size (2016-2027)
6.2 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type
6.2.1 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021)
6.2.2 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027)
6.2.3 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2027)
6.3 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application
6.3.1 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021)
6.3.2 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027)
6.3.3 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2027)
6.4 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country
6.4.1 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021)
6.4.2 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size (2016-2027)
7.2 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type
7.2.1 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2027)
7.3 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application
7.3.1 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2027)
7.4 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country
7.4.1 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type
8.2.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application
8.3.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Region
8.4.1 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size (2016-2027)
9.2 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type
9.2.1 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2027)
9.3 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application
9.3.1 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2027)
9.4 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country
9.4.1 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type
10.2.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application
10.3.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country
10.4.1 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.1.4 Abbott Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.2.4 Danaher Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.2.5 Danaher Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.3.4 Roche Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.4.4 BD Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.4.5 BD Recent Development
11.5 Boston Scientific
11.5.1 Boston Scientific Company Details
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.5.4 Boston Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.5.5 Boston Scientific Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.7.4 Bio-Rad Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.7.5 Bio-Rad Recent Development
11.8 Merck Millipore
11.8.1 Merck Millipore Company Details
11.8.2 Merck Millipore Business Overview
11.8.3 Merck Millipore Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.8.4 Merck Millipore Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.8.5 Merck Millipore Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.9.4 Agilent Technologies Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.9.5 Agilent Technologies Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.10.4 Thermo Fisher Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.11.4 Qiagen Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.11.5 Qiagen Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.12.4 PerkinElmer Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.12.5 PerkinElmer Recent Development
11.13 CooperSurgical
11.13.1 CooperSurgical Company Details
11.13.2 CooperSurgical Business Overview
11.13.3 CooperSurgical Sex Cord Gonadal Stromal Tumor Treatment Introduction
11.13.4 CooperSurgical Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
11.13.5 CooperSurgical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Surgery
Table 5. Key Players of Others
Table 6. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2016-2021)
Table 10. Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2022-2027)
Table 12. Sex Cord Gonadal Stromal Tumor Treatment Market Trends
Table 13. Sex Cord Gonadal Stromal Tumor Treatment Market Drivers
Table 14. Sex Cord Gonadal Stromal Tumor Treatment Market Challenges
Table 15. Sex Cord Gonadal Stromal Tumor Treatment Market Restraints
Table 16. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Players (2016-2021)
Table 18. Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor Treatment as of 2020)
Table 19. Ranking of Global Top Sex Cord Gonadal Stromal Tumor Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Sex Cord Gonadal Stromal Tumor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sex Cord Gonadal Stromal Tumor Treatment Product Solution and Service
Table 23. Date of Enter into Sex Cord Gonadal Stromal Tumor Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Sex Cord Gonadal Stromal Tumor Treatment Product
Table 66. Abbott Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher Sex Cord Gonadal Stromal Tumor Treatment Product
Table 71. Danaher Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 72. Danaher Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Sex Cord Gonadal Stromal Tumor Treatment Product
Table 76. Roche Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD Sex Cord Gonadal Stromal Tumor Treatment Product
Table 81. BD Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 82. BD Recent Development
Table 83. Boston Scientific Company Details
Table 84. Boston Scientific Business Overview
Table 85. Boston Scientific Sex Cord Gonadal Stromal Tumor Treatment Product
Table 86. Boston Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 87. Boston Scientific Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Sex Cord Gonadal Stromal Tumor Treatment Product
Table 91. Johnson & Johnson Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 92. Johnson & Johnson Recent Development
Table 93. Bio-Rad Company Details
Table 94. Bio-Rad Business Overview
Table 95. Bio-Rad Sex Cord Gonadal Stromal Tumor Treatment Product
Table 96. Bio-Rad Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 97. Bio-Rad Recent Development
Table 98. Merck Millipore Company Details
Table 99. Merck Millipore Business Overview
Table 100. Merck Millipore Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 101. Merck Millipore Recent Development
Table 102. Agilent Technologies Company Details
Table 103. Agilent Technologies Business Overview
Table 104. Agilent Technologies Sex Cord Gonadal Stromal Tumor Treatment Product
Table 105. Agilent Technologies Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 106. Agilent Technologies Recent Development
Table 107. Thermo Fisher Scientific Company Details
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Sex Cord Gonadal Stromal Tumor Treatment Product
Table 110. Thermo Fisher Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Qiagen Company Details
Table 113. Qiagen Business Overview
Table 114. Qiagen Sex Cord Gonadal Stromal Tumor Treatment Product
Table 115. Qiagen Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 116. Qiagen Recent Development
Table 117. PerkinElmer Company Details
Table 118. PerkinElmer Business Overview
Table 119. PerkinElmer Sex Cord Gonadal Stromal Tumor Treatment Product
Table 120. PerkinElmer Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 121. PerkinElmer Recent Development
Table 122. CooperSurgical Company Details
Table 123. CooperSurgical Business Overview
Table 124. CooperSurgical Sex Cord Gonadal Stromal Tumor Treatment Product
Table 125. CooperSurgical Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021) & (US$ Million)
Table 126. CooperSurgical Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Surgery Features
Figure 5. Others Features
Figure 6. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Sex Cord Gonadal Stromal Tumor Treatment Report Years Considered
Figure 12. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2022-2027)
Figure 16. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Players in 2020
Figure 17. Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Sex Cord Gonadal Stromal Tumor Treatment Revenue in 2020
Figure 19. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2016-2027)
Figure 23. North America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2016-2027)
Figure 24. North America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Country (2016-2027)
Figure 25. United States Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2016-2027)
Figure 29. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2016-2027)
Figure 30. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Share by Country (2016-2027)
Figure 31. Germany Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Share by Region (2016-2027)
Figure 41. China Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Sex Cord Gonadal Stromal Tumor Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 61. Danaher Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 63. BD Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 64. Boston Scientific Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 66. Bio-Rad Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 67. Merck Millipore Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 68. Agilent Technologies Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 70. Qiagen Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 71. PerkinElmer Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 72. CooperSurgical Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の性索性腺間質腫瘍市場規模・現状・予測（2021年-2027年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, …- 世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 世界の消化管間質腫瘍（GIST）治療市場規模・現状・予測（2021年-2027年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 世界の脳腫瘍治療市場規模・現状・予測（2021年-2027年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …